Silence Therapeutics GAAP EPS of -$0.63, revenue of $0.5M
Source: SeekingAlpha
2026-03-05 17:05:03 ET
More on Silence Therapeutics
- Seeking Alpha’s Quant Rating on Silence Therapeutics
- Historical earnings data for Silence Therapeutics
- Financial information for Silence Therapeutics
Read the full article on Seeking Alpha
For further details see:
Silence Therapeutics GAAP EPS of -$0.63, revenue of $0.5M
Silence Therapeutics Plc
NASDAQ: SLN
SLN Trading
0.57% G/L:
$6.205 Last:
153,174 Volume:
$6.14 Open:
SLN Latest News
SLN Stock Data
$207,324,000
44,881,200
58.7%
11
N/A
Biotechnology & Life Sciences
Healthcare
GB
London
